FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 66 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $290,000 | +119.7% | 87,474 | +100.0% | 0.00% | – |
| Q3 2019 | $132,000 | +26.9% | 43,737 | 0.0% | 0.00% | – |
| Q2 2019 | $104,000 | +40.5% | 43,737 | +119.0% | 0.00% | – |
| Q1 2019 | $74,000 | -47.9% | 19,970 | -50.0% | 0.00% | – |
| Q4 2018 | $142,000 | +24.6% | 39,940 | +100.0% | 0.00% | – |
| Q3 2018 | $114,000 | +14.0% | 19,970 | 0.0% | 0.00% | – |
| Q2 2018 | $100,000 | -2.0% | 19,970 | 0.0% | 0.00% | – |
| Q1 2018 | $102,000 | -15.0% | 19,970 | 0.0% | 0.00% | – |
| Q4 2017 | $120,000 | +9.1% | 19,970 | 0.0% | 0.00% | – |
| Q3 2017 | $110,000 | +19.6% | 19,970 | 0.0% | 0.00% | – |
| Q2 2017 | $92,000 | -7.1% | 19,970 | -0.6% | 0.00% | – |
| Q1 2017 | $99,000 | -45.9% | 20,093 | +21.5% | 0.00% | – |
| Q4 2016 | $183,000 | +41.9% | 16,531 | +17.9% | 0.00% | – |
| Q3 2016 | $129,000 | +46.6% | 14,017 | +0.6% | 0.00% | – |
| Q2 2016 | $88,000 | -64.7% | 13,929 | -63.6% | 0.00% | – |
| Q1 2016 | $249,000 | -8.8% | 38,243 | +13.6% | 0.00% | – |
| Q4 2015 | $273,000 | +16.2% | 33,669 | +4.6% | 0.00% | – |
| Q3 2015 | $235,000 | -17.8% | 32,186 | +15.2% | 0.00% | – |
| Q2 2015 | $286,000 | – | 27,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|